Mycobacterium tuberculosis sterilizing activity of faropenem, pyrazinamide and linezolid combination and failure to shorten the therapy duration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mycobacterium tuberculosis sterilizing activity of faropenem, pyrazinamide and linezolid combination and failure to shorten the therapy duration

Published:2021-03 Issue: Volume:104 Page:680-684
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Gumbo Tawanda,Sherman Carleton M.,Deshpande Devyani,Alffenaar Jan-Willem,Srivastava Shashikant

Funder

National Institute of Allergy and Infectious Diseases

National Institute of Child Health and Human Development

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference26 articles.

1. Linezolid-based regimens for multidrug-resistant tuberculosis (TB): a systematic review to establish or revise the current recommended dose for TB treatment;Bolhuis;Clin Infect Dis,2018

2. Treatment of highly drug-resistant pulmonary tuberculosis;Conradie;N Engl J Med,2020

3. Intrapulmonary concentrations of pyrazinamide;Conte;Antimicrob Agents Chemother,1999

4. Antibacterial and sterilizing effect of benzylpenicillin in tuberculosis;Deshpande;Antimicrob Agents Chemother,2018

5. Antibacterial and sterilizing effect of benzylpenicillin in tuberculosis;Deshpande;Antimicrob Agents Chemother,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of the Hollow-Fiber Infection Model to Personalized Precision Dosing of Isoniazid in a Clinical Setting;Journal of Korean Medical Science;2024

2. Meropenem-vaborbactam restoration of first-line drug efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen;International Journal of Antimicrobial Agents;2023-12

3. The In vitro activity of carbapenems alone and in combination with β-lactamase inhibitors against difficult-to-treat mycobacteria; Mycobacterium tuberculosis, Mycobacterium abscessus, and Mycobacterium avium complex: A systematic review;INT J MYCOBACT;2023

4. Eradication of Drug-Tolerant Mycobacterium tuberculosis 2022: Where We Stand;Microorganisms;2023-06-06

5. T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren;Antimicrobial Agents and Chemotherapy;2022-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3